The associations between fibrosis changes and liver-related events in patients with metabolic dysfunction-associated steatotic liver disease.

Hye-Won LeeKun Hee KimSang Hoon AhnHan Chu LeeJonggi Choi

Published in: Liver international : official journal of the International Association for the Study of the Liver (2024)

LSM changes could predict clinical outcomes in patients with MASLD. Thus, it is important to monitor changes in the fibrotic burden by regular assessment of LSM values.

Keyphrases

systemic sclerosis
oxidative stress
risk factors
clinical evaluation